Skip to main content

Table 1 Demographic and Clinical Characteristics of Diabetes Cohort and Drug Treatment Categories*,†

From: Barriers to self-monitoring of blood glucose among adults with diabetes in an HMO: A cross sectional study

  Managed Without Drugs (n = 1,346) Insulin-Managed (n = 1,428 Oral Sulfonylurea-Managed (n = 1,791)
Characteristics N (%) N (%) N (%)
Gender       
   Male 600 (44.6) 697 (48.8) 1,003 (56.0)
   Female 746 (55.4) 731 (51.2) 788 (44.0)
Mean Age 52 ± 14.2 51 ± 14.1 56 ± 12.3
Race N (%) N (%) N (%)
   White 747 (75.5) 652 (65.6) 814 (68.5)
   Black 180 (18.2) 305 (30.7) 300 (25.2)
   Other 62 (6.3) 37 (3.7) 75 (6.3)
   Missing 357 --- 434 --- 602 ---
Eligibility       
   Medicaid 17 (1.3) 10 (0.7) 7 (0.4)
   Medicare 238 (17.8) 242 (17.2) 420 (23.7)
   Commercial 1,079 (80.9) 1,159 (82.1) 1,345 (75.9)
   Missing 12 --- 17 --- 19 ---
Body Mass Index       
   Underweight 13 (1.2) 13 (1.1) 11 (0.8)
   Normal 220 (19.5) 249 (21.2) 201 (13.9)
   Overweight 370 (32.8) 377 (32.0) 441 (30.4)
   Obese 525 (46.5) 538 (45.7) 797 (55.0)
   Missing 218 --- 251 --- 341 ---
Comorbidities       
   None 444 (33.0) 27 (1.9) 45 (2.5)
   1–2 570 (42.4) 628 (44.0) 837 (46.7)
   3–4 250 (18.6) 446 (31.2) 626 (35.0)
   5 or More 82 (6.1) 327 (22.9) 283 (15.8)
Avg # of Comorbidities 1.57 ± 1.62   3.12 ± 2.06   2.83 ± 1.73  
  1. * All percentages are calculated for those with non-missing data. †All differences between characteristics for the insulin-managed and oral sulfonylurea managed groups were significant at the 0.02 level (p < 0.01). ‡ For the Body Mass Index(BMI) variable: underweight = BMI ≤ 18.5 kg/m2, normal = 18.6 < BMI < 25 kg/m2, overweight = 25.0 ≤ BMI < 30.0 kg/m2, and obese = BMI ≥ 30 kg/m2